Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 6 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $908K (30,311 shares) of Maze Therapeutics, Inc. on Jul 1, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | Chief Executive Officer, Director | Jan 30, 2025 | Oct 2, 2026 |
| Braveheart Bio, Inc. (BRVE) | Director | Aug 5, 2026 | Aug 5, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, Maze Therapeutics, Inc.: sold 34,501 shares for $932K, under a disclosed plan (some held indirectly). 1 filing: 1
- Sep 3, 2026, Maze Therapeutics, Inc.: sold 11,411 shares for $297K, to cover taxes. 1 filing: 1
- Sep 2, 2026, Maze Therapeutics, Inc.: sold 11,227 shares for $297K, to cover taxes. 1 filing: 1
- Sep 1, 2026, Maze Therapeutics, Inc.: sold 34,501 shares for $907K, under a disclosed plan; 50,000 shares vested (some held indirectly). 1 filing: 1
- Aug 3, 2026, Maze Therapeutics, Inc.: sold 34,501 shares for $922K, under a disclosed plan (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.